Search
for
Sort by
Research 31–60 of 1000+
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- PATTERN OF CUTANEOUS MANIFESTATIONS OF DIABETES MELLITUS
- Real-world evidence in alopecia areata treatment: A narrative review
- The pharmacology of methotrexate
- Cutaneous reactions to recombinant cytokine therapy
- Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser
- Scalp Pruritus: Review of the Pathogenesis, Diagnosis, and Management
- Recurrence of Pemphigus Vulgaris Associated With Interleukin 2 Therapy
- PROFILE OF SKIN CHANGES AND ITS ASSOCIATION WITH BIOCHEMICAL PARAMETERS IN HAEMODIALYSIS PATIENTS
- Neuropathic Pruritus: An Underrecognized and Often Misdiagnosed and Difficult to Treat Medical Condition
- Hepatotoxicity Secondary to A Drug to Lose Weight, "Orlistat": to take into Account as a Differential Diagnosis
- The Itchy Scalp
- Poster Abstracts
- Alopecias
- Nephrogenic systemic fibrosis: Report of two cases
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Treatment-Refractory Central Centrifugal Cicatricial Alopecia Responsive to a Novel Botanical Treatment
- Real-World Effectiveness, Safety, and Tolerability of Cetosomal Minoxidil 5% Alone and a Fixed Drug Combination of Cetosomal Minoxidil 5% With Finasteride 0.1% in the Management of Androgenetic Alopecia (Inbilt Study)
- Experimental aspects concerning the laser action on the living tissue
- Effects of Turmeric (<i>Curcuma longa</i>) on Skin Health: A Systematic Review of the Clinical Evidence
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Diet in dermatology: Revisited
- Skin disorders in elderly subjects
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Pregnancy and Skin
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Dermatologic Reactions to Targeted Therapy
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Cutaneuos findings in patients with predialysis chronic kidney disease
- Cutaneous Reactions to Drugs